IOT Stock Overview
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Innovotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.17 |
| 52 Week High | CA$0.19 |
| 52 Week Low | CA$0.02 |
| Beta | 1.22 |
| 11 Month Change | 29.63% |
| 3 Month Change | 25.00% |
| 1 Year Change | 84.21% |
| 33 Year Change | -20.45% |
| 5 Year Change | 133.33% |
| Change since IPO | -16.67% |
Recent News & Updates
Shareholder Returns
| IOT | CA Life Sciences | CA Market | |
|---|---|---|---|
| 7D | 16.7% | -7.2% | 0.4% |
| 1Y | 84.2% | 1.2% | 21.4% |
Return vs Industry: IOT exceeded the Canadian Life Sciences industry which returned 1.2% over the past year.
Return vs Market: IOT exceeded the Canadian Market which returned 21.4% over the past year.
Price Volatility
| IOT volatility | |
|---|---|
| IOT Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: IOT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine IOT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Craig Milne | innovotech.ca |
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.
Innovotech Inc. Fundamentals Summary
| IOT fundamental statistics | |
|---|---|
| Market cap | CA$5.93m |
| Earnings (TTM) | -CA$268.25k |
| Revenue (TTM) | CA$1.49m |
4.8x
P/S Ratio-26.7x
P/E RatioIs IOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IOT income statement (TTM) | |
|---|---|
| Revenue | CA$1.49m |
| Cost of Revenue | CA$429.78k |
| Gross Profit | CA$1.06m |
| Other Expenses | CA$1.33m |
| Earnings | -CA$268.25k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0066 |
| Gross Margin | 71.15% |
| Net Profit Margin | -18.01% |
| Debt/Equity Ratio | 9.3% |
How did IOT perform over the long term?
See historical performance and comparison